Air Liquide (AL) recently announced that it has entered into exclusive negotiations with EQT, a global investment organization, for the potential sale of its subsidiary Schülke & Mayr, a global leader in infection prevention and hygiene.

This potential sale, as previously announced in November 2019, illustrates AL’s strategy to review its business portfolio regularly and to focus on its core gases and healthcare businesses.

AL intends to continue to develop its healthcare activities, while providing Schülke & Mayr GmbH with the best opportunity for its long-term development.